Orion Vaccines
Dr. Hana Kim · VP Regulatory Strategy KB v1Deal stage
— where this deal is in its journey, first contact to closeDeal snapshot
Win chance, the value at stake, and how far this deal has come.
Win chance
Weighted to $183K
Value at stake
Full value vs. risk-adjusted.
Pipeline progress
Qualified · 16d since touch
Orion Vaccines is cooling in Qualified — 16 days since the last touch, $365K at risk. Recommended next move: Re-engage Orion Vaccines.
Recommended: Re-engage Orion Vaccines
A quick read on this deal from your agent — where it stands and the smartest next move — so you're prepared before you call or email. The agent never reaches out on its own.
Deal value
$365K
The full amount if it closes.
Weighted
$183K
50% chance of closing
Owner
Suren DheenWho's running this deal — that's you.
Last activity
Your most recent logged call, email, or note — 16 days ago.
Next step scheduled: Jul 26, 2026
Agent — next best action for this deal
Re-engage Orion Vaccines
No activity in 16 days on a $365K deal sitting at "Qualified" — it's going cold. Draft a value nudge to bring it back.
Follow up with Orion Vaccines
You set a follow-up with Orion Vaccines for 7/26/2026. Draft the recap with a concrete next step so it doesn't slip.
Recommended Services
Position Regulatory Intelligence against Orion Vaccines's near-term regulatory milestones.
Single-pane monitoring across FDA, EMA and 120+ agencies.
Activity
- InterestedJul 6, 2026 • 4:30 PM
Wants global guidance monitoring.
Follow-up Jul 26, 2026Logged by Suren Dheen